Featured Products

My Quote Request

No products added yet

6505-00-347-2306

20 Products

PEDIAMYCIN

ERYTHROMYCIN ETHYLSUCCINATE FOR ORAL SUSPENSION,USP

NSN, MFG P/N

6505003472306

NSN

6505-00-347-2306

View More Info

PEDIAMYCIN

ERYTHROMYCIN ETHYLSUCCINATE FOR ORAL SUSPENSION,USP

NSN, MFG P/N

6505003472306

NSN

6505-00-347-2306

MFG

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 90.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: BOTTLE

74-6346

ERYTHROMYCIN STEARATE TABLETS,USP

NSN, MFG P/N

6505003443519

NSN

6505-00-344-3519

View More Info

74-6346

ERYTHROMYCIN STEARATE TABLETS,USP

NSN, MFG P/N

6505003443519

NSN

6505-00-344-3519

MFG

PUBLIC HEALTH SERVICE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:NONENTERIC FILM

0994

BARIUM SULFATE FOR SUSPENSION,USP

NSN, MFG P/N

6505003471907

NSN

6505-00-347-1907

View More Info

0994

BARIUM SULFATE FOR SUSPENSION,USP

NSN, MFG P/N

6505003471907

NSN

6505-00-347-1907

MFG

LAFAYETTE PHARMACAL DIV OF ALCON LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 95.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BARIUM SULFATE FOR SUSPENSION USP 95% 8OZ CUP SINGLE DOSE 36S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 OUNCES OR 224.000 GRAMS
PRIMARY CONTAINER TYPE: CUP, UNIT DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 36

79208

BARIUM SULFATE FOR SUSPENSION,USP

NSN, MFG P/N

6505003471907

NSN

6505-00-347-1907

View More Info

79208

BARIUM SULFATE FOR SUSPENSION,USP

NSN, MFG P/N

6505003471907

NSN

6505-00-347-1907

MFG

LAFAYETTE PHARMACAL DIV OF ALCON LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 95.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BARIUM SULFATE FOR SUSPENSION USP 95% 8OZ CUP SINGLE DOSE 36S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 OUNCES OR 224.000 GRAMS
PRIMARY CONTAINER TYPE: CUP, UNIT DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 36

BAROSPERSE UNIVERSAL CUP

BARIUM SULFATE FOR SUSPENSION,USP

NSN, MFG P/N

6505003471907

NSN

6505-00-347-1907

View More Info

BAROSPERSE UNIVERSAL CUP

BARIUM SULFATE FOR SUSPENSION,USP

NSN, MFG P/N

6505003471907

NSN

6505-00-347-1907

MFG

LAFAYETTE PHARMACAL DIV OF ALCON LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 95.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BARIUM SULFATE FOR SUSPENSION USP 95% 8OZ CUP SINGLE DOSE 36S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 OUNCES OR 224.000 GRAMS
PRIMARY CONTAINER TYPE: CUP, UNIT DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 36

NDC00019-0994-14

BARIUM SULFATE FOR SUSPENSION,USP

NSN, MFG P/N

6505003471907

NSN

6505-00-347-1907

View More Info

NDC00019-0994-14

BARIUM SULFATE FOR SUSPENSION,USP

NSN, MFG P/N

6505003471907

NSN

6505-00-347-1907

MFG

MALLINCKRODT INC ANESTHESIA PRODUCTS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 95.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BARIUM SULFATE FOR SUSPENSION USP 95% 8OZ CUP SINGLE DOSE 36S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 OUNCES OR 224.000 GRAMS
PRIMARY CONTAINER TYPE: CUP, UNIT DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 36

NDC00224-0621-08

BARIUM SULFATE FOR SUSPENSION,USP

NSN, MFG P/N

6505003471907

NSN

6505-00-347-1907

View More Info

NDC00224-0621-08

BARIUM SULFATE FOR SUSPENSION,USP

NSN, MFG P/N

6505003471907

NSN

6505-00-347-1907

MFG

LAFAYETTE PHARMACAL DIV OF ALCON LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 95.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BARIUM SULFATE FOR SUSPENSION USP 95% 8OZ CUP SINGLE DOSE 36S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 OUNCES OR 224.000 GRAMS
PRIMARY CONTAINER TYPE: CUP, UNIT DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 36

NDC59081-0621-08

BARIUM SULFATE FOR SUSPENSION,USP

NSN, MFG P/N

6505003471907

NSN

6505-00-347-1907

View More Info

NDC59081-0621-08

BARIUM SULFATE FOR SUSPENSION,USP

NSN, MFG P/N

6505003471907

NSN

6505-00-347-1907

MFG

LAFAYETTE PHARMACAL DIV OF ALCON LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 95.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BARIUM SULFATE FOR SUSPENSION USP 95% 8OZ CUP SINGLE DOSE 36S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 OUNCES OR 224.000 GRAMS
PRIMARY CONTAINER TYPE: CUP, UNIT DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 36

NDC00597-0025-04

MESORIDAZINE BESYLA

NSN, MFG P/N

6505003471909

NSN

6505-00-347-1909

View More Info

NDC00597-0025-04

MESORIDAZINE BESYLA

NSN, MFG P/N

6505003471909

NSN

6505-00-347-1909

MFG

BOEHRINGER INGELHEIM PHARMACEUTICALS INC.

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: LIQUID,25 MG PER ML,4 OZ BOTTLE W/GRADUATED DROPPER,FLAVORED,FOR ORAL USE

SERENTIL ORAL CONCENTRATE

MESORIDAZINE BESYLA

NSN, MFG P/N

6505003471909

NSN

6505-00-347-1909

View More Info

SERENTIL ORAL CONCENTRATE

MESORIDAZINE BESYLA

NSN, MFG P/N

6505003471909

NSN

6505-00-347-1909

MFG

BOEHRINGER INGELHEIM PHARMACEUTICALS INC.

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: LIQUID,25 MG PER ML,4 OZ BOTTLE W/GRADUATED DROPPER,FLAVORED,FOR ORAL USE

6505-000-1177

TRIOXSALEN TABLETS

NSN, MFG P/N

6505003472177

NSN

6505-00-347-2177

View More Info

6505-000-1177

TRIOXSALEN TABLETS

NSN, MFG P/N

6505003472177

NSN

6505-00-347-2177

MFG

DEPARTMENT OF HEALTH EDUCATION AND WELFARE HEALTH SERVICES AND MENTAL HEALTH ADMINISTRATION

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 MG TRIOXSALEN PER TABLET,COATED,UNITPKG TYPE-BOTTLE,UNIT PKG QTY-100

6505-000-1456

5-AMINOSALICYLIC ACID TABLETS

NSN, MFG P/N

6505003472178

NSN

6505-00-347-2178

View More Info

6505-000-1456

5-AMINOSALICYLIC ACID TABLETS

NSN, MFG P/N

6505003472178

NSN

6505-00-347-2178

MFG

DEPARTMENT OF HEALTH EDUCATION AND WELFARE HEALTH SERVICES AND MENTAL HEALTH ADMINISTRATION

Description

PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 0.5 GM;BACTERIOSTATIC AGAINST MYCOBACTERIUM TB

KETALAR

KETAMINE HYDROCHLORIDE INJECTION,USP

NSN, MFG P/N

6505003472199

NSN

6505-00-347-2199

View More Info

KETALAR

KETAMINE HYDROCHLORIDE INJECTION,USP

NSN, MFG P/N

6505003472199

NSN

6505-00-347-2199

MFG

PARKE-DAVIS DIV OF WARNER-LAMBERT CO

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS KETAMINE HYDROCHLORIDE EQUIVALENT
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE

KETALAR

KETAMINE HYDROCHLORIDE INJECTION,USP

NSN, MFG P/N

6505003472201

NSN

6505-00-347-2201

View More Info

KETALAR

KETAMINE HYDROCHLORIDE INJECTION,USP

NSN, MFG P/N

6505003472201

NSN

6505-00-347-2201

MFG

PARKE-DAVIS DIV OF WARNER-LAMBERT CO

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS KETAMINE HYDROCHLORIDE EQUIVALENT PER MILLILITER
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE

904-439

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS,USP

NSN, MFG P/N

6505003472223

NSN

6505-00-347-2223

View More Info

904-439

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS,USP

NSN, MFG P/N

6505003472223

NSN

6505-00-347-2223

MFG

PARKE-DAVIS DIV OF WARNER-LAMBERT CO

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.050 MILLIGRAMS ETHYLENEIMINE QUINONE ACTIVE INGREDIENT AND 1.000 MILLIGRAMS NORETHINDRONE ACETATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 28.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: COMPACT REFILL,INCLUDES 7 FERROUS TABLETS

904-438

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS,USP

NSN, MFG P/N

6505003472232

NSN

6505-00-347-2232

View More Info

904-438

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS,USP

NSN, MFG P/N

6505003472232

NSN

6505-00-347-2232

MFG

PARKE-DAVIS DIV OF WARNER-LAMBERT CO

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.050 MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT AND 1.000 MILLIGRAMS NORETHINDRONE ACETATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 28.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: COMPACT REFILL,INCLUDES 7 FERROUS FUMERATE TABLETS

XVIII

METHYLDOPA TABLETS,USP

NSN, MFG P/N

6505003472239

NSN

6505-00-347-2239

View More Info

XVIII

METHYLDOPA TABLETS,USP

NSN, MFG P/N

6505003472239

NSN

6505-00-347-2239

MFG

PUBLIC HEALTH SERVICE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS METHYLDOPA ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:NONENTERIC FILM

PHENF0RMIN

PHENFORMIN HYDROCHLORIDE EXTENDED-RELEASE CAPSULES

NSN, MFG P/N

6505003472240

NSN

6505-00-347-2240

View More Info

PHENF0RMIN

PHENFORMIN HYDROCHLORIDE EXTENDED-RELEASE CAPSULES

NSN, MFG P/N

6505003472240

NSN

6505-00-347-2240

MFG

PUBLIC HEALTH SERVICE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PHENFORMIN HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 30.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LONG ACTION METHOD:EXTENDED RELEASE;

PHENF0RMIN

PHENFORMIN HYDROCHLORIDE EXTENDED-RELEASE CAPSULES

NSN, MFG P/N

6505003472287

NSN

6505-00-347-2287

View More Info

PHENF0RMIN

PHENFORMIN HYDROCHLORIDE EXTENDED-RELEASE CAPSULES

NSN, MFG P/N

6505003472287

NSN

6505-00-347-2287

MFG

PUBLIC HEALTH SERVICE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PHENFORMIN HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 60.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LONG ACTION METHOD:EXTENDED RELEASE;

1001DERM0PLAST

BENZOCAINE,BENZETHONIUM CHLORIDE,HYDROXYQUINOLINE BENZOATE,MENTHOL,AND METHYLPARABEN AEROSOL

NSN, MFG P/N

6505003472291

NSN

6505-00-347-2291

View More Info

1001DERM0PLAST

BENZOCAINE,BENZETHONIUM CHLORIDE,HYDROXYQUINOLINE BENZOATE,MENTHOL,AND METHYLPARABEN AEROSOL

NSN, MFG P/N

6505003472291

NSN

6505-00-347-2291

MFG

WYETH

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS BENZETHONIUM CHLORIDE PER MILLILITER AND 45.000 MILLIGRAMS BENZOCAINE PER MILLILITER AND 20.000 MILLIGRAMS METHYLPARABEN PER MILLILITER AND 12.000 MILLIGRAMS 8-HYDROXYQUINOLINE BENZOATE PER MILLILITER
ADMINISTRATION: TOPICAL
PRIMARY CONTAINER CONTENT QUANTITY: 11.000 OUNCES
PRIMARY CONTAINER TYPE: CAN, AEROSOL
TOTAL PRIMARY CONTAINER QUANTITY: 1